Statistics
Total Visits
| Views | |
|---|---|
| HAPTOGLOBIN PHENOTYPE, HDL-CHOLESTEROL RAISING THERAPY (FIBRATE), AND RISK OF CARDIOVASCULAR DISEASE EVENTS WITHIN THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES (ACCORD) LIPID TRIAL | 132 |
Total Visits Per Month
| March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | |
|---|---|---|---|---|---|---|---|
| HAPTOGLOBIN PHENOTYPE, HDL-CHOLESTEROL RAISING THERAPY (FIBRATE), AND RISK OF CARDIOVASCULAR DISEASE EVENTS WITHIN THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES (ACCORD) LIPID TRIAL | 4 | 5 | 13 | 4 | 8 | 19 | 4 |
File Visits
| Views | |
|---|---|
| Warren-Rachel-MSc-CH&E-August-2020.pdf | 455 |
Top country views
| Views | |
|---|---|
| United States | 75 |
| China | 9 |
| Canada | 7 |
| Japan | 6 |
| Russia | 5 |
| Vietnam | 5 |
| Ireland | 4 |
| Argentina | 3 |
| Australia | 2 |
| Bulgaria | 2 |
Top cities views
| Views | |
|---|---|
| Blue Bell | 11 |
| Houston | 9 |
| Oakland | 8 |
| Tokyo | 6 |
| Wilmington | 6 |
| Fairfield | 5 |
| Hanoi | 5 |
| Dublin | 4 |
| Menlo Park | 4 |
| Ottawa | 4 |